The Established Nuclear Medicine Modalities for Imaging of Bone Metastases-Reference-Cited by-同舟云学术

The Established Nuclear Medicine Modalities for Imaging of Bone Metastases

Published:2019-10-16 Issue:9 Volume:15 Page:819-830
ISSN:1573-4056
Container-title:Current Medical Imaging Formerly Current Medical Imaging Reviews
language:en
Short-container-title:CMIR

Author:

Jabeen Nazish¹,Rasheed Rashid²,Rafique Asma¹,Murtaza Ghulam¹

Affiliation:

1. Department of Pharmacy, COMSATS Institute of Information Technology Abbottabad, Abbottabad, Pakistan

2. Institute of Nuclear Medicines, Oncology and Radiations (INOR), Ayub Medical Hospital, Abbottabad, Pakistan

Abstract

Background: The skeleton is one of the frequent site of metastases in advanced cancer. Prostate, breast and renal cancers mostly metastasize to bone. Discussion: Malignant tumors lead to significant morbidity and mortality. Identification of bone lesions is a crucial step in diagnosis of disease at early stage, monitoring of disease progression and evaluation of therapy. Diagnosis of cancer metastases is based on uptake of bone-targeted radioactive tracer at different bone remodeling sites. Conclusion: This manuscript summarizes already established and evolving nuclear medicine modalities (e.g. bone scan, SPECT, SPECT/CT, PET, PET/CT) for imaging of bone metastases.

Publisher

Bentham Science Publishers Ltd.

Subject

Radiology Nuclear Medicine and imaging

Reference96 articles.

1. Ozgenc E.; Ekinci M.; Ilem-Ozdemir D.; Radiolabeling and in vitro evaluation of 99mTc-methotrexate on breast cancer cell line. J Radioanal Nucl Chem 2016,307(1),627-633

2. Mundy G.R.; Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002,2(8),584-593

3. Nayir E.; Pathogenesis of bone metastasis. J Oncol Sci 2016,1,13-16

4. Cuccurullo V.; Cascini G.L.; Tamburrini O.; Rotondo A.; Mansi L.; Bone metastases radiopharmaceuticals: an overview. Curr Radiopharm 2013,6(1),41-47

5. Qiu L.; Cheng W.; Lin J.; Synthesis and evaluation of a series of 99mTc-labelled zoledronic acid derivatives as potential bone seeking agents. J Radioanal Nucl Chem 2013,295(1),545-552

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All that illuminates on radionuclide imaging is not a metastatic lesion: Role of complementary imaging;Indian Journal of Musculoskeletal Radiology;2023-03-31

2. Targeting bone microenvironments for treatment and early detection of cancer bone metastatic niches;Journal of Controlled Release;2022-01

3. Evaluation of the Small-animal Nano Scan PET/CT System using 89Zr;Current Medical Imaging Formerly Current Medical Imaging Reviews);2021-03-16